BetterLife Pharma Inc. Files June 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Jun 17, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Jun 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, foreign-private-issuer
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its June 6-K, standard foreign private issuer update.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on June 17, 2024, reporting for the month of June 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is incorporated in A1 and has its principal executive office in Vancouver, BC. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding BetterLife Pharma Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain significant new financial or operational information that would typically increase risk.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer of the 6-K report
- Pivot Pharmaceuticals Inc. (company) — Former company name
- Neurokine Pharmaceuticals Inc. (company) — Former company name
- 20240617 (date) — Filing date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. after a name change on April 17, 2015, and prior to that, as Neurokine Pharmaceuticals Inc. after a name change on May 14, 2009.
Where is BetterLife Pharma Inc.'s principal executive office located?
BetterLife Pharma Inc.'s principal executive office is located at 1275 West 6th Avenue, #300, Vancouver, BC V6H 1A6.
Does BetterLife Pharma Inc. file annual reports under Form 20-F or 40-F?
BetterLife Pharma Inc. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for BetterLife Pharma Inc.?
The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 343 words · 1 min read · ~1 pages · Grade level 14.7 · Accepted 2024-06-17 16:53:27
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 32KB
- betrf_ex991img3.jpg (GRAPHIC) — 4KB
- betrf_ex991img4.jpg (GRAPHIC) — 4KB
- 0001477932-24-003730.txt ( ) — 54KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: June 17, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3